CropLogic technology used on real crops in real time

Published 27-MAR-2019 14:25 P.M.


4 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.

Click Here to View Latest Articles

Award winning global agricultural technology company CropLogic Ltd (ASX:CLI) has provided a further update on its progress in entering the multi-billion dollar US hemp market.

As reported by Finfeed at the start of last week, the company’s wholly-owned Oregonian subsidiary LogicalCropping LLC was issued a registered industrial hemp growers licence by the Oregon Department of Agriculture, a development that has seen its shares more than double since then.

However, CropLogic’s investment prospects extend beyond the revenues it should derive from selling its maiden crop towards the latter part of 2019.

The company provides cutting-edge technology to growers for decision support, and this will be utilised in growing its hemp crop to optimise yields from its trial 150 acre hemp farm in Oregon.

Consequently, the group will have the opportunity to showcase its technology which is already widely used across a variety of agricultural crops.

More specifically, the company aims to facilitate the hemp production process through the use of its innovative hardware and software package, CropLogic realTime.

Readily accessible Realtime data

The hardware technology monitors and tracks key crop metrics, such as soil moisture and irrigation, and as the name suggests converts observations into data for access via a range of platforms in real time.

This information is then collated in a concise and accurate format, providing actionable insights for users to make cost-saving decisions.

Users can view this data in a user-friendly application called CropLogic GrowerView, which can be accessed via desktop, as well as on both Android and Apple iOS.

CropLogic has developed this tool with the expertise of leading agronomists, leveraging over 30 years of research.

Following the introduction of the 2018 federal Farm Bill, it was reported that the number of licensed growers had climbed from 13 to 584, and hemp acreage had swelled from essentially zero to more than 11,000 acres according to the Oregon Department of Agriculture.

CBD and cannabis research organisation, Brightfield Group estimates that the value of the US hemp market will triple to US$22 billion by 2022.

Vertically integrated operation

This represents extremely promising news for a company such as CropLogic as it is positioned to generate income at every point in the supply chain from crop planting and growing through to harvesting and the generation of income from sales.

The company will also benefit from supply chain management which usually results in improved efficiencies and better margins.

Importantly, the company will be one of a small number of ASX listed players in the sector to generate revenues in 2019 with income from the sale of its hemp crop grown in Oregon expected to deliver income in the order of $15 million.

Revenue achieved from this crop will be available to support the further product push and development of CropLogic’s suite of agricultural technology products, including CropLogic realTime.

On this note, James Cooper-Jones, CropLogic chief executive said, “CropLogic is excited to apply its considerable agronomy and agtech knowledge on this trial farm this season.

“CropLogic endeavours to be at the forefront of industry, agronomy and agtech innovation trends.”

By demonstrating the company’s agronomy and technologies, CropLogic positions itself to benefit from a lucrative and expanding market.

CropLogic and LogicalCropping are in discussions with several potential offtake partners, and the group is also investigating potential participation in the process of its hemp biomass beneficiation and processing into CBD (cannabidiol) products.

Proof will be in the pudding

On the growing side, CropLogic has received its first shipment of industrial hemp seed through its wholly owned Oregonian subsidiary LogicalCropping LLC.

These seeds have been delivered to a third party nursery experienced in industrial hemp for germination before planting in May.

They were sourced from a supplier in Oregon that has a track record of delivering high yields from high potency, disease resistant seeds.

Over the next eight months, there will be a number of milestone events for CropLogic, many of which have the potential to impact the company’s share price.

For example, news regarding planting in May/June, flowering in August/September, harvesting in September/October and sale proceeds in October/November will all be signposts as to CropLogic’s progress in generating substantial income, as well as being an indication of the success of the company’s technology.

General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.


Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free